Mitochondria‑Targeted Galactose Nanodots for Ferroptosis‑Boosted Photodynamic Therapy of Hypoxic Liver Cancer
Aggregate · 2026-11 · 7 (11)
DOI: 10.1002/agt2.70476 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aggregate, online erschienen am 10.11.2026. Verfasst von Jin Gong und 9 weiteren Autor:innen. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Liver cancer therapy demands innovative therapeutic paradigms to circumvent the limitations of hypoxia resistance and nonspecific toxicity inherent in conventional photodynamic therapy (PDT). Herein, we report a glycocluster‐directed nanoplatform IC2@Gal , engineered via the self‐assembly of a photosensitizer (PS) with both Type I and Type II photochemical activity ( IC2 ) with galactose‐coated glycoclusters based on a perylenediimide core scaffold ( PDI‐Gal 4 ). This design leverages asialoglycoprotein receptor‐mediated active targeting to achieve precise tumor accumulation, as evidenced by rapid in vivo imaging and complete tumor elimination in HepG2 tumor‐bearing mice. The cationic nature of IC2 ensures mitochondrial anchoring, while the glycocluster architecture promotes cellular internalization and dispersibility. Upon irradiation, IC2 exhibits aggregation‐induced generation of reactive oxygen species, including Type I radical species and Type II singlet oxygen. Its substantial Type I activity is consistent with the retained phototoxicity of IC2@Gal under hypoxia, accompanied by ferroptosis‐associated lipid peroxidation and reduced GPX4 expression. Impressively, a single administration of IC2@Gal combined with localized light exposure achieved complete tumor ablation without observable systemic toxicity. This work not only validates glycocluster‐mediated self‐assembly as a robust strategy for converting hydrophobic PSs into targeted nanomedicines but also serves as a valuable reference for precision oncology that integrates targeted delivery, hypoxia‐tolerant ferroptosis, and mitochondrial PDT.
Förderung
- Natural Science Foundation of Shandong Province
Zitieren
APA
Gong, J., Zhang, T., Xing, J., Li, W., Zhang, K., Tan, M., Dong, L., Zhang, Z., Vidal, S., & Han, H. (2026). Mitochondria‑Targeted Galactose Nanodots for Ferroptosis‑Boosted Photodynamic Therapy of Hypoxic Liver Cancer. Aggregate, 7(11). https://doi.org/10.1002/agt2.70476
Vancouver
Gong J, Zhang T, Xing J, Li W, Zhang K, Tan M, et al. Mitochondria‑Targeted Galactose Nanodots for Ferroptosis‑Boosted Photodynamic Therapy of Hypoxic Liver Cancer. Aggregate. 2026;7(11). doi:10.1002/agt2.70476
BibTeX
@article{Gong2026,
author = {Gong, Jin and Zhang, Tian‐Han and Xing, Jing and Li, Wen‐Jia and Zhang, Ke‐Xin and Tan, Ming‐Chao and Dong, Lei and Zhang, Zhong and Vidal, Sébastien and Han, Hai‐Hao},
title = {Mitochondria‑Targeted Galactose Nanodots for Ferroptosis‑Boosted Photodynamic Therapy of Hypoxic Liver Cancer},
journal = {Aggregate},
year = {2026},
volume = {7},
number = {11},
doi = {10.1002/agt2.70476}
}
EUVIMED